参考文献/References:
［1］Gray, R H, CAMPBELL O M, et al. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays ［J］. The Journal of Clinical Endocrinology and Metabolism, 1987, 64 (4): 645-650.
［2］World Health Organization Task Force on Methods for the Natural Regulation of Fertility .The World Health Organization multinational study of breast-feeding and lactational amenorrhea.IV.Postpartum bleeding and lochia in breast-feeding women［J］.Fertil Steril，1999，72（3）：431-441．
［3］BAHAMONDES L, BRACHE V, MEIRIK O, et al. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls ［J］. Human Reproduction, 2015, 30 (11): 2527-2538.
［4］BIRGISSON N E, ZHAO Qiu-hong, SECURA G M, et al. Preventing unintended pregnancy: the contraceptive CHOICE project in review ［J］. Journal of Women's Health, 2015, 24 (5): 349-353.
［5］AIKEN A R, CREININ M D, KAUNITZ A M, et al. Global fee prohibits postpartum provision of the most effective reversible contraceptives ［J］. Contraception, 2014, 90 (5): 466-467.
［6］Committee Opinion No.670 Summary:Immediate Postpartum Long-Acting Reversible Contraception ［J］.Obstet Gynecol, 2016, 128 (2): 422-423.
［7］SONALKAR S, KAPP N. Intrauterine device insertion in the postpartum period: A systematic review ［J］. European Journal of Contraception and Reproductive Health Care, 2015, 20 (1): 4-18.
［8］GRIMES D A, LOPEZ L M, SCHULZ K F, et al. Immediate post-partum insertion of intrauterine devices ［J］. Cochrane Database of Systematic Reviews, 2010 (5): CD003036.
［9］EGGEBROTEN J L, SANDERS J N, TUROK D K. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis ［J］. American Journal of Obstetrics and Gynecology, 2017, 217 (1): 51.
［10］GOLDSTUCK N D, WILDEMEERSCH D A. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices ［J］. Obstetrics and Gynecology, 2014, 123 (6, SI): 1356-1357.
［11］WHITACRE F E, LOEB L. The time for postpartum sterilization;report of 150 cases;bacteriologic studies on the postpartum uterus ［J］. American Journal of Obstetrics and Gynecology, 1946, 52 (6): 1041-1053.
相似文献/References:
[1]陈诚,常青.瘢痕子宫剖宫产围手术期处理[J].中国计划生育和妇产科,2012,(04):0.
CHEN Cheng,CHANG Qing*.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[2]李力,韩磊.产后避孕的昨天、今天与未来[J].中国计划生育和妇产科,2012,(06):0.
LI Li,HAN Lei PLA Family Planning Technique Center,Daping Hospital of The Third Military Medical University,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[3]吴尚纯,楚光华.产后避孕的国内外指南[J].中国计划生育和妇产科,2012,(06):0.
WU Shang-chun,CHU Guang-hua ..[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[4]金力.产后避孕的必要性及知情选择[J].中国计划生育和妇产科,2012,(06):0.
JIN Li.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[5]熊薇,刘兴会.从产科视角看产后避孕[J].中国计划生育和妇产科,2012,(06):0.
XIONG Wei,LIU Xing-hui* West China Second Hospital,Sichuan University,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[6]柳宛璐,吴媛媛,乔福元,等.分娩方式与产后避孕[J].中国计划生育和妇产科,2012,(06):0.
LIU Wan-lu,WU Yuan-yuan,QIAO Fu-yuan* Deptment of Obstetrics and Gynecology,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[7]刘欣燕.产后避孕的严峻现状和新挑战[J].中国计划生育和妇产科,2019,(1):3.
[8]滕莉荣,邱琳,欧婕,等.产后避孕时机的把握[J].中国计划生育和妇产科,2019,(1):7.
[9]胡惠英,马骁,李春颖*,等.产后口服避孕药的正确选择[J].中国计划生育和妇产科,2019,(1):11.
[10]陈蔚琳,吕昌帅,刘欣燕*.产后避孕认识的误区及对策[J].中国计划生育和妇产科,2019,(1):15.